Bernard Jones to Rituximab
This is a "connection" page, showing publications Bernard Jones has written about Rituximab.
Connection Strength
0.031
-
Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma. Am J Hematol. 2016 May; 91(5):476-80.
Score: 0.031